Organovo Affirms Key Clinical Development Goals; Company Reports Fiscal Third-Quarter 2019 Results – Nasdaq

Pre-Investigational New Drug meeting with the FDA expected to be held in calendar 2019 Submit first IND in calendar 2020. SAN DIEGO, Feb. 07, 2019–.